MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Compliance Implementation Services
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CIS Hires Seasoned Veteran for Government Programs Team – Plans West Coast Expansion - Linda Schock takes on West Coast-based Director, Government Programs Consulting role and will open future CIS office - CIS-Partners.com
CIS Hires Seasoned Veteran for Government Programs Team – Plans West Coast Expansion

 

NewswireToday - /newswire/ - Media, PA, United States, 2011/06/07 - Linda Schock takes on West Coast-based Director, Government Programs Consulting role and will open future CIS office - CIS-Partners.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Linda Schock has joined the firm as Director, Government Pricing and will oversee the launch of the future CIS West Coast office.

Schock brings over 20 years of industry experience which spans distribution, pricing, managed care and Government contracting, reimbursement and Patient Support Programs to her consulting role on the firm’s Government Programs team. She will assist clients in understanding the impact of healthcare reform on their organizations by reviewing compliance and methodology, systems and processes, organization and financial statements, as well as oversee the company’s management of Government Statutory Pricing calculations using the CalcPartner™ service line. Schock will ensure client compliance in the development of pricing calculations and strategy for all government contracts, including Average Manufacturer’s Price (AMP), Best Price (BP), Medicaid Rebate Per Unit (RPU) and 340B Public Health Service ceiling prices. Schock will be responsible for spearheading and expanding Government Programs Consulting efforts from CIS’ new office, which will be an addition to the company’s headquarters near Philadelphia, Pennsylvania and Raleigh, North Carolina.

“We are delighted to welcome Linda Schock as the newest addition to our Government Programs team. She brings a strong commercial and government operations background to CIS and represents a key hire in the company’s overall growth,” said Amy VanDeCar, Director, US Commercial Compliance and Government Programs at CIS. “We know she will be an asset in opening the future office on the West Coast, allowing us to better serve our expanding client base.”

Most recently, Schock was Director, Commercial Operations for NeurogesX and launched the product Qutenza®. Prior to NeurogesX she was Director, Pricing, Contracts and Reimbursement in Commercial Operations at CV Therapeutics, launching Ranexa® until its acquisition by Gilead Sciences in 2009. From 2001 to 2005 Schock was Associate Director, Distribution & Reimbursement in Commercial Sales Operations at Actelion Pharmaceuticals, launching the product Tracleer®. Schock began her career at Genentech, Inc. where she worked in commercial operations positions of increasing responsibility from 1987 to 2001, most recently as Manager, Government Contract Operations.

About CIS
Compliance Implementation Services (CIS) is a consulting firm specializing in compliance strategies for the pharmaceutical industry, from Global Clinical Research and Development, through Manufacturing, U.S. Commercial Compliance, and Government Programs. Founded in 2004, CIS (cis-partners.com) provides its clients with a deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions to establish a “Culture of Compliance” that is both meaningful and sustainable.

CIS experts identify, assess and prioritize an organization’s exposure to compliance risks, subsequently developing and implementing risk evaluation and mitigation techniques to ensure adherence to legal and regulatory requirements.

CalcPartner™ is a trademark of Compliance Implementation Services, LLC.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Compliance Implementation Services

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CIS Hires Seasoned Veteran for Government Programs Team – Plans West Coast Expansion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Christine Pahl- CIS-Partners.com 
484-445-7254 christinepahl[.]cis-partners.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Compliance Implementation Services securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Compliance Implementation Services / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)